Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
0
Canada
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
1. Brl 14151
2. Brl-14151
3. Brl14151
4. Clavulanate
5. Clavulanate, Potassium
6. Clavulanate, Sodium
7. Clavulanic Acid
8. Clavulanic Acid, Monopotassium Salt
9. Clavulanic Acid, Monosodium Salt
10. Mm 14151
11. Mm-14151
12. Mm14151
13. Potassium Clavulanate
14. Potassium, Clavulanate
15. Sodium Clavulanate
1. Potassium Clavulanate
2. 61177-45-5
3. Clavulanic Acid Potassium Salt
4. Brl 14151k
5. Clavulanate (potassium)
6. Q42omw3at8
7. Chebi:85264
8. Brl-14151k
9. Potassium (2r,3z,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
10. Potassium (z)-(2r,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylate
11. Potassium;(2r,3z,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
12. Amonate
13. Potassium (2r,5r,z)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
14. Clavulansaeure Kaliumsalz
15. Einecs 262-640-9
16. Unii-q42omw3at8
17. Potassium Clavlanate
18. Clavulanate Potassium [usan:usp:jan]
19. Chembl1003
20. Schembl203411
21. Clavulanic Acid Potassium
22. Hy-a0256a
23. Dtxsid60210067
24. Hms3715b13
25. Clavulanate Potassium (jp17/usp)
26. Potassium Clavulanate [jan]
27. Bcp13548
28. Clavulanate Potassium [usan]
29. Clavulanate Potassium [vandf]
30. Potassium Clavulanate [mart.]
31. Potassium Clavulanate Cellulose(1:1)
32. Akos015961326
33. Clavulanate Potassium [who-dd]
34. Ccg-221126
35. 4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3-(2-hydroxyethylidene)-7-oxo-, Monopotassium Salt, (2r-(2alpha,3z,5alpha))-
36. Ac-13551
37. Bp-30181
38. Clavulanate Potassium [green Book]
39. Potassium (2r-(2alpha,3z,5alpha))-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylate
40. Clavulanate Potassium [orange Book]
41. Potassium Clavulanate [ep Monograph]
42. Clavulanate Potassium [usp Monograph]
43. Cs-0019771
44. Augmentin Component Clavulanate Potassium
45. C-6660
46. Clavulox Component Clavulanate Potassium
47. D02370
48. D84066
49. Timentin Component Clavulanate Potassium
50. A833076
51. Clavulanate Potassium Component Of Augmentin
52. Clavulanate Potassium Component Of Clavulox
53. Clavulanate Potassium Component Of Timentin
54. Clavulanic Acid (as Clavulanate Potassium)
55. Clavulanic Acid Potassium 100 Microg/ml In Water
56. W-105420
57. Clavulanate Potassium+microcrystalline Cellulose(1:1)
58. Potassium Clavulanate (40%) : Silicon Dioxide Mixture
59. Q27158444
60. Potassium Clavulanate (50%) : Microcrystalline Cellulose
61. Clavulanate Potassium Salt, Antibiotic For Culture Media Use Only
62. Potassium Clavulanate - 1:1 Mixture With Cellulose, Antibiotic For Culture Media Use Only
63. (2r,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2beta-carboxylic Acid Potassium Salt
64. 4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3-(2-hydroxyethylidene)-7-oxo-, Monopotassium Salt, (2r-(2.alpha.,3z,5.alpha.))-
65. Potassium (2r,3z,5r)-3-(2-oxidanylethylidene)-7-oxidanylidene-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
66. Potassium (2r,5r,z)- 3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
67. Potassium(2r,5r,z)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
Molecular Weight | 237.25 g/mol |
---|---|
Molecular Formula | C8H8KNO5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 237.00395384 g/mol |
Monoisotopic Mass | 237.00395384 g/mol |
Topological Polar Surface Area | 89.9 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 329 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
beta-Lactamase Inhibitors
Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-29
Pay. Date : 2014-02-13
DMF Number : 25714
Submission : 2012-01-16
Status : Active
Type : II
Certificate Number : R1-CEP 2011-376 - Rev 02
Issue Date : 2021-03-01
Type : Chemical
Substance Number : 1653
Status : Valid
NDC Package Code : 42677-104
Start Marketing Date : 2007-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2018-01-16
Registration Number : 20120615-113-F-69-16(1)
Manufacturer Name : Shandong New Time Pharmaceutical Co.,Ltd.
Manufacturer Address : No.1, North Outer Ring Road, Feixian County, Shandong Province, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25718
Submission : 2012-01-16
Status : Active
Type : II
Certificate Number : R1-CEP 2011-375 - Rev 02
Issue Date : 2021-04-08
Type : Chemical
Substance Number : 1653
Status : Valid
NDC Package Code : 42677-104
Start Marketing Date : 2007-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2018-01-16
Registration Number : 20120615-113-F-69-16(1)
Manufacturer Name : Shandong New Time Pharmaceutical Co.,Ltd.
Manufacturer Address : No.1, North Outer Ring Road, Feixian County, Shandong Province, China
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-10-06
Pay. Date : 2014-03-31
DMF Number : 27903
Submission : 2014-02-05
Status : Active
Type : II
Certificate Number : R1-CEP 2014-329 - Rev 00
Issue Date : 2021-03-03
Type : Chemical
Substance Number : 1653
Status : Valid
NDC Package Code : 55657-105
Start Marketing Date : 2006-02-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/2kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2014-10-10
Registration Number : 20141010-113-F-78-23
Manufacturer Name : Sinopharm Weiqida Pharmaceutical Co., Ltd.
Manufacturer Address : Pharmaceutical Industrial Park, Economic & Technological Development Zone, Datong, Shanxi, China
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-09-08
Pay. Date : 2014-03-31
DMF Number : 27966
Submission : 2014-03-12
Status : Active
Type : II
Certificate Number : R1-CEP 2014-320 - Rev 00
Issue Date : 2021-03-05
Type : Chemical
Substance Number : 1140
Status : Valid
NDC Package Code : 55657-105
Start Marketing Date : 2006-02-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/2kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2014-10-10
Registration Number : 20141010-113-F-78-23
Manufacturer Name : Sinopharm Weiqida Pharmaceutical Co., Ltd.
Manufacturer Address : Pharmaceutical Industrial Park, Economic & Technological Development Zone, Datong, Shanxi, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19677
Submission : 2006-06-16
Status : Inactive
Type : II
Certificate Number : R1-CEP 2011-374 - Rev 00
Issue Date : 2017-12-15
Type : Chemical
Substance Number : 1140
Status : Valid
NDC Package Code : 42677-104
Start Marketing Date : 2007-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2018-01-16
Registration Number : 20120615-113-F-69-16(1)
Manufacturer Name : Shandong New Time Pharmaceutical Co.,Ltd.
Manufacturer Address : No.1, North Outer Ring Road, Feixian County, Shandong Province, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4349
Submission : 1981-12-02
Status : Inactive
Type : II
Certificate Number : R1-CEP 1999-113 - Rev 04
Issue Date : 2014-02-26
Type : Chemical
Substance Number : 1140
Status : Valid
Registrant Name : GlaxoSmithKline Inc.
Registration Date : 2020-03-10
Registration Number : 20200310-113-F-91-24
Manufacturer Name : SmithKline Beecham Pharmaceuticals
Manufacturer Address : Shewalton Road, Irvine, KA11 5AP United Kingdom
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5701
Submission : 1985-02-13
Status : Inactive
Type : II
Certificate Number : R1-CEP 1999-111 - Rev 03
Issue Date : 2018-08-03
Type : Chemical
Substance Number : 1140
Status : Valid
Registrant Name : GlaxoSmithKline Inc.
Registration Date : 2020-03-10
Registration Number : 20200310-113-F-91-24
Manufacturer Name : SmithKline Beecham Pharmaceuticals
Manufacturer Address : Shewalton Road, Irvine, KA11 5AP United Kingdom
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7048
Submission : 1987-07-09
Status : Inactive
Type : II
Certificate Number : R1-CEP 2005-244 - Rev 01
Issue Date : 2017-12-01
Type : Chemical
Substance Number : 1653
Status : Valid
Registrant Name : GlaxoSmithKline Inc.
Registration Date : 2020-03-10
Registration Number : 20200310-113-F-91-24
Manufacturer Name : SmithKline Beecham Pharmaceuticals
Manufacturer Address : Shewalton Road, Irvine, KA11 5AP United Kingdom
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14065
Submission : 1999-04-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14436
Submission : 1999-10-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4349
Submission : 1981-12-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16005
Submission : 2002-06-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7048
Submission : 1987-07-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5701
Submission : 1985-02-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15211
Submission : 2000-12-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-13
Pay. Date : 2018-06-21
DMF Number : 14679
Submission : 2000-01-19
Status : Active
Type : II
Potassium clavulanate, diluted, with microcrystalline Cellulose in the ratio 7:3
Certificate Number : R1-CEP 2009-358 - Rev 00
Status : Valid
Issue Date : 2015-02-17
Type : Chemical
Substance Number : 1653
Potassium clavulanate, diluted, with silica, colloidal anhydrous in a ratio of 1:1
Certificate Number : R1-CEP 2006-018 - Rev 02
Status : Valid
Issue Date : 2014-12-08
Type : Chemical
Substance Number : 1653
Potassium clavulanate, diluted, silica, colloidal hydrated in a ratio 1:1
Certificate Number : R0-CEP 2006-068 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2010-02-02
Type : Chemical
Substance Number : 1653
Potassium clavulanate, Sterile
Certificate Number : R1-CEP 1999-113 - Rev 04
Status : Valid
Issue Date : 2014-02-26
Type : Chemical
Substance Number : 1140
Potassium clavulanate, diluted, with microcrystalline cellulose in a ratio of 3:2
Certificate Number : R0-CEP 2004-234 - Rev 01
Status : Expired
Issue Date : 2009-10-13
Type : Chemical
Substance Number : 1653
Certificate Number : R1-CEP 1997-087 - Rev 04
Status : Withdrawn by Holder
Issue Date : 2010-01-12
Type : Chemical
Substance Number : 1140
Potassium clavulanate, diluted, with microcrystalline cellulose in the ratio 1:1
Certificate Number : R0-CEP 2008-148 - Rev 00
Status : Expired
Issue Date : 2010-08-05
Type : Chemical
Substance Number : 1653
Certificate Number : R0-CEP 2008-147 - Rev 00
Status : Expired
Issue Date : 2010-08-05
Type : Chemical
Substance Number : 1140
Potassium clavulanate, diluted, with silicon dioxide in the ratio 1:1
Certificate Number : R0-CEP 2008-146 - Rev 00
Status : Expired
Issue Date : 2010-08-05
Type : Chemical
Substance Number : 1653
Potassium clavulanate, diluted, with silica, colloidal hydrated in a ratio of 1:1
Certificate Number : R1-CEP 2002-256 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2010-01-12
Type : Chemical
Substance Number : 1653
Registrant Name : Inistesti Co., Ltd.
Registration Date : 2018-01-25
Registration Number : 20090617-113-F-45-14(5)
Manufacturer Name : Fermic, SA de. CV
Manufacturer Address : Reforma No. 873 Col. San Nicolas Tolentino Iztapalapa, 09850, Mexico
Registrant Name : GlaxoSmithKline Inc.
Registration Date : 2020-03-10
Registration Number : 20200310-113-F-91-24
Manufacturer Name : SmithKline Beecham Pharmaceu...
Manufacturer Address : Shewalton Road, Irvine, KA11 5AP United Kingdom
Registrant Name : Boryeong Co., Ltd.
Registration Date : 2015-09-09
Registration Number : 20081031-113-F-9-04(2)
Manufacturer Name : Lek Pharmaceuticals dd
Manufacturer Address : Perzonali 47, SI-2391 Prevalje
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2022-04-25
Registration Number : 20220425-113-F-96-26
Manufacturer Name : Lek farmacevtska družba dd,...
Manufacturer Address : Trimlini 2D, Lendava, 9220, Slovenia
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2022-04-25
Registration Number : 20220425-113-F-95-25
Manufacturer Name : Lek farmacevtska družba dd,...
Manufacturer Address : Trimlini 2D, Lendava, 9220, Slovenia
Registrant Name : Yuhan Corporation
Registration Date : 2018-02-08
Registration Number : 20081031-113-F-10-03(4)
Manufacturer Name : lek pharmaceuticals dd
Manufacturer Address : Perzonali 47, SI-2391 Prevalje
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2018-01-16
Registration Number : 20120615-113-F-69-16(1)
Manufacturer Name : Shandong New Time Pharmaceut...
Manufacturer Address : No.1, North Outer Ring Road, Feixian County, Shandong Province, China
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2017-10-25
Registration Number : 20120615-113-F-68-17(4)
Manufacturer Name : Shandong New Time Pharmaceut...
Manufacturer Address : No.1, North Outer Ring Road, Feixian County, Shandong Province, China
Registrant Name : Boryeong Co., Ltd.
Registration Date : 2017-07-27
Registration Number : 20120615-113-F-68-17(3)
Manufacturer Name : Shandong New Time Pharmaceut...
Manufacturer Address : No.1, North Outer Ring Road, Feixian County, Shandong Province, China
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2017-10-25
Registration Number : 20120615-113-F-67-18(4)
Manufacturer Name : Shandong New Time Pharmaceut...
Manufacturer Address : No.1, North Outer Ring Road, Feixian County, Shandong Province, China
NDC Package Code : 52972-0042
Start Marketing Date : 2023-07-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (0.7kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 52972-0031
Start Marketing Date : 2003-02-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52972-0034
Start Marketing Date : 2005-06-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 52972-0033
Start Marketing Date : 2005-06-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 39390-0043
Start Marketing Date : 2018-11-23
End Marketing Date : 2028-01-13
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39390-0045
Start Marketing Date : 2024-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39390-0044
Start Marketing Date : 2018-11-23
End Marketing Date : 2028-01-13
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39390-0046
Start Marketing Date : 2024-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48866-9981
Start Marketing Date : 2022-11-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 42677-105
Start Marketing Date : 2007-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : ACTILLETS™ are microcrystalline cellulose spheres used in advanced drug formulations as starter cores for drug layering and coating.
Pharmacopoeia Ref : NA
Technical Specs : Bulk density: 0.80
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Orodispersible Tablet
Grade : Oral
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?